S. Michael Rothenberg
Publications by Year
Research Areas
Protein Tyrosine Phosphatases, RNA modifications and cancer, Colorectal Cancer Treatments and Studies, Biochemical and Molecular Research, Melanoma and MAPK Pathways
Most-Cited Works
- → Isolation of circulating tumor cells using a microvortex-generating herringbone-chip(2010)1,618 cited
- → Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer(2020)816 cited
- → Efficacy of Selpercatinib in RET -Altered Thyroid Cancers(2020)741 cited
- → EGFR and EphA2 are host factors for hepatitis C virus entry and possible targets for antiviral therapy(2011)688 cited
- → Selective RET kinase inhibition for patients with RET-altered cancers(2018)426 cited
- → A Next-Generation TRK Kinase Inhibitor Overcomes Acquired Resistance to Prior TRK Kinase Inhibition in Patients with TRK Fusion–Positive Solid Tumors(2017)425 cited
- → Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib(2014)362 cited
- → The molecular pathogenesis of head and neck squamous cell carcinoma(2012)359 cited
- → Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profiling(2007)358 cited
- → RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies(2020)276 cited